Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System
NCT02471807 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2023-03-28
Summary
The study is a multi-center, prospective, early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function, provide guidance for future clinical study designs and development efforts of the Edwards FORMA Tricuspid Transcatheter Repair System.
Conditions
- Tricuspid Valve Regurgitation
Interventions
- DEVICE
-
Edwards FORMA Tricuspid Transcatheter Repair System
Sponsors & Collaborators
-
Edwards Lifesciences
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2019-06-30
- Completion
- 2023-01-17
Countries
- United States
Study Locations
More Related Trials
-
Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation
NCT07140562 ·Status: RECRUITING ·Phase: NA
-
Trisol System EFS Study
NCT04905017 ·Status: RECRUITING ·Phase: NA
-
Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement
NCT04717570 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
EFS of the DUO System for Tricuspid Regurgitation
NCT05913908 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of Edwards Cardioband FIT Valve Repair System
NCT03382457 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study
NCT02722551 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
NCT03632967 ·Status: TERMINATED ·Phase: NA
-
Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)
NCT03779490 ·Status: ACTIVE_NOT_RECRUITING
-
The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System
NCT02787408 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
NCT04100720 ·Status: WITHDRAWN ·Phase: NA
-
A First in Human Study for the Versa Device for Tricuspid Regurgitation
NCT06368401 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Caisson Transcatheter Mitral Valve Replacement (TMVR) System Early Feasibility Study
NCT02768402 ·Status: UNKNOWN ·Phase: NA
-
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
NCT02276547 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Feasibility Study of the CroíValve DUO System for Tricuspid Regurgitation
NCT05296148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
NCT04890821 ·Status: RECRUITING ·Phase: NA
-
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
NCT04029337 ·Status: RECRUITING ·Phase: NA
-
Cardiovalve Transfemoral Mitral Valve System
NCT03813524 ·Status: TERMINATED ·Phase: NA
-
Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)
NCT02515539 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
NCT05848284 ·Status: RECRUITING ·Phase: NA
-
EFS of the CardioMech MVRS
NCT04820764 ·Status: RECRUITING ·Phase: NA
-
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
NCT02574650 ·Status: UNKNOWN ·Phase: NA
-
MiCLASP Post Market Clinical Follow-Up (PMCF) Study
NCT04430075 ·Status: RECRUITING
-
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
NCT02397668 ·Status: RECRUITING ·Phase: NA
-
Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System
NCT03714412 ·Status: WITHDRAWN ·Phase: NA
-
TTVR Early Feasibility Study
NCT04433065 ·Status: RECRUITING ·Phase: NA